Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariet Allen

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2020
Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's diseaseChia-Chen Liu, Yu Yamazaki, Michael G Heckman, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
Scientific Data|October 12, 2016
Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseasesMariet Allen, Minerva M Carrasquillo, Cory Funk, et al.
Nature Communications|April 20, 2021
Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's diseaseAngela M Crist, Kelly M Hinkle, Xue Wang, et al.
Molecular Neurodegeneration|October 18, 2018
ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African AmericansOlivia J Conway, Minerva M Carrasquillo, Xue Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2017
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseasesMariet Allen, Xue Wang, Jeremy D Burgess, et al.
Genome Medicine|November 30, 2017
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resiliencePerry G Ridge, Celeste M Karch, Simon Hsu, et al.
Alzheimer'S Research & Therapy|October 18, 2014
Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levelsMariet Allen, Michaela Kachadoorian, Zachary Quicksall, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2020
Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's diseaseChia-Chen Liu, Yu Yamazaki, Michael G Heckman, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
Scientific Data|October 12, 2016
Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseasesMariet Allen, Minerva M Carrasquillo, Cory Funk, et al.
Nature Communications|April 20, 2021
Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's diseaseAngela M Crist, Kelly M Hinkle, Xue Wang, et al.
Molecular Neurodegeneration|October 18, 2018
ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African AmericansOlivia J Conway, Minerva M Carrasquillo, Xue Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2017
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseasesMariet Allen, Xue Wang, Jeremy D Burgess, et al.
Genome Medicine|November 30, 2017
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resiliencePerry G Ridge, Celeste M Karch, Simon Hsu, et al.
Alzheimer'S Research & Therapy|October 18, 2014
Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levelsMariet Allen, Michaela Kachadoorian, Zachary Quicksall, et al.
Pageof 9